US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 1.770
  • -0.180-9.23%
Close Mar 18 16:00 ET
  • 1.760
  • -0.010-0.56%
Post 18:01 ET
191.35MMarket Cap-1.49P/E (TTM)

About Tango Therapeutics Company

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

Company Profile

SymbolTNGX
Company NameTango Therapeutics
Listing DateSep 3, 2020
Issue Price10.00
Founded2017
CEODr. Barbara L. Weber, M.D.
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 901
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-320-4900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Barbara L. Weber, M.D.
  • President, Chief Executive Officer and Director
  • 3.39M
  • Douglas Barry
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Daniella Beckman
  • Chief Financial Officer
  • 1.52M
  • Julie Carretero
  • Chief Human Resources Officer
  • --
  • Alexis A. Borisy, A.M.
  • Chairman of the Board
  • 171.53K
  • Dr. Adam Crystal, M.D.,PhD
  • President, Research and Development
  • 3.11M
  • Dr. Mace Rothenberg, M.D.
  • Independent Director
  • 141.53K
  • Dr. Malte Peters, M.D.
  • Independent Director
  • 139.03K
  • Lesley Ann Calhoun
  • Independent Director
  • 148.03K
  • John B. Ketchum
  • Independent Director
  • 375.87K
  • Kanishka Pothula
  • Independent Director
  • --

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Fed’s March rate decision nears: Market pivot ahead?
How will the Fed's rate decision impact short-term trends in U.S. stocks? How would you reposition your portfolio? Show More